Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-01-10 @ 2:47 PM
Study NCT ID:
NCT02238158
Status:
COMPLETED
Last Update Posted:
2014-09-12
First Post:
2014-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-09
Start Date Type:
None
Primary Completion Date:
2001-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-09-11
First Submit QC Date:
None
Study First Post Date:
2014-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-09-11
Last Update Post Date:
2014-09-12
Last Update Post Date Type:
ESTIMATED